Engene Holdings Inc (ENGN)
$6.61
+0.08
(+1.23%)▲
Market is closed - opens 7 PM, 09 Sep 2024
Performance
- $6.48$6.93$6.61
1.97%
Downside
Day's Volatility :6.49%
Upside
4.62%
- $4.94$43.00$6.61
25.3%
Downside
52 Weeks Volatility :88.52%
Upside
84.63%
Returns
| Period | Engene Holdings Inc | Index (Russel 2000) |
|---|---|---|
3 Months | -22.24% | 0.0% |
6 Months | -58.66% | 0.0% |
1 Year | -66.95% | 0.0% |
3 Years | -66.95% | -22.3% |
Highlights
Market Capitalization | 291.9M |
Book Value | $5.5 |
Earnings Per Share (EPS) | -2.64 |
Wall Street Target Price | 32.14 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -29.38% |
Return On Equity TTM | -330.6% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
EBITDA | -44.5M |
Diluted Eps TTM | -2.64 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -1.54 |
EPS Estimate Next Year | -1.68 |
EPS Estimate Current Quarter | -0.26 |
EPS Estimate Next Quarter | 0.0 |
Analyst Recommendation
Buy
90%Buy
9%Hold
0
0%Sell
Based on 11 Wall street analysts offering stock ratings for Engene Holdings Inc(by analysts ranked 0 to 5 stars)
Analyst Forecast
What analysts predicted
Upside of 386.23%
Current $6.61
Target $32.14
Technicals Summary
Sell
Neutral
Buy
Engene Holdings Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Engene Holdings Inc | -5.97% | -58.66% | -66.95% | -66.95% | -66.95% |
 Regeneron Pharmaceuticals, Inc. | 5.97% | 16.25% | 37.11% | 69.18% | 305.56% |
 Novo Nordisk A/s | 9.99% | -3.52% | 34.24% | 158.74% | 417.73% |
 Alnylam Pharmaceuticals, Inc. | -5.15% | 64.67% | 22.72% | 31.08% | 198.44% |
 Vertex Pharmaceuticals Incorporated | 0.45% | 14.0% | 36.06% | 143.5% | 167.72% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Engene Holdings Inc | NA | NA | NA | -1.54 | -3.31 | -0.29 | NA | 5.5 |
Regeneron Pharmaceuticals, Inc. | 29.93 | 29.93 | 1.54 | 45.05 | 0.17 | 0.08 | NA | 261.41 |
Novo Nordisk A/s | 44.01 | 44.01 | 1.98 | 3.44 | 0.89 | 0.23 | 0.01 | 25.24 |
Alnylam Pharmaceuticals, Inc. | NA | NA | -0.49 | -2.55 | -15.01 | 0.02 | NA | -0.02 |
Vertex Pharmaceuticals Incorporated | 32.84 | NA | 0.57 | 0.32 | -0.03 | 0.13 | NA | 57.26 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Engene Holdings Inc | Buy | $291.9M | -66.95% | NA | 0.0% |
Regeneron Pharmaceuticals, Inc. | Buy | $124.7B | 305.56% | 29.93 | 32.04% |
Novo Nordisk A/s | Buy | $585.3B | 417.73% | 44.01 | 34.84% |
Alnylam Pharmaceuticals, Inc. | Buy | $32.3B | 198.44% | NA | -3.11% |
Vertex Pharmaceuticals Incorporated | Buy | $120.9B | 167.72% | 32.84 | -4.74% |
Company Information
Organization | Engene Holdings Inc |
Employees | 31 |
CEO | Dr. Alex Nichols Ph.D. |
Industry | Miscellaneous |
Discover More
A Spac I Acquisition Corp
$6.61
+1.23%
Keyarch Acquisition Corp
$6.61
+1.23%
Connexa Sports Technologies Inc
$6.61
+1.23%
Us Value Etf
$6.61
+1.23%
First Wave Biopharma Inc
$6.61
+1.23%
Global X Msci Next Emerging
$6.61
+1.23%
Fat Projects Acquisition Corp
$6.61
+1.23%
Capital Link Global Fintech
$6.61
+1.23%
Applied Uv Inc
$6.61
+1.23%